This report summarizes the meeting on “Improving Priority Antibiotic Access in Thailand and Regional Coordinated Procurement Mechanisms,” held on 7–8 July 2025 in Bangkok, Thailand. The meeting was convened by the Health Intervention and Technology Assessment Program Foundation (HITAP), in collabora

Situation of Clean Air Rooms and Air Purifiers in Thailand Thailand continues to experience persistent fine particulate matter with a diameter of 2.5 micrometers or less (PM2.5), posing significant risks to public health, particularly among vulnerable populations. About 13.6 mill

This article is part 1 of the blog series: “Knowledge Translation: The Key to Turning Mathematical Models from a Black Box into a Powerful Tool for Policy Decision-Making” As health systems become more complex, decision-makers need tools that can help them evaluate long-term outcomes and choose

The report summarises a visit to Tanzania and has been prepared by Mr. Panupong Chaowanasawat and Dr. Brandon Chua from the Health Intervention and Technology Assessment Program Foundation (HITAP), Thailand. The study visit was supported by the Access and Delivery Partnership (ADP), led by the Unite

Countries across Asia are increasingly turning to health technology assessment (HTA) to ensure healthcare decisions are guided by appropriate evidence. However, many still face challenges in institutionalizing HTA, including building technical expertise, applying economic evaluation in decision-maki

Gao Qi is a research assistant at Saw Swee Hock School of Public Health, National University of Singapore in collaboration with MIDAS. Research fields include framework construction of health innovation process, early health technology assessment, and traditional health technology assessment. Interested in health policy effects and health innovatio

Apiwat Piriyapol is a research associate at Medical Innovation Development and Assessment Support (MIDAS). His training was in labour economics with experience in urban health economics. His current interest is in conducting medical technology assessment to promote advanced technology to the healthcare system.

Dr. Teerawat Wiwatpanit is a biomedical scientist by training. His expertise includes early health technology assessment, innovation development, and biomedical engineering for disease modeling and drug testing. He is passionate about promoting an efficient innovation landscape and translating scientific discoveries into practical healthcare soluti

Asst. Prof. Dr. Wang Yi is a co-founder of Medical Innovation Development and Assessment Support (MIDAS). His research areas include early health technology assessment, traditional health technology assessment, population’s preference for health and healthcare, and economic evaluation/analysis using real-world data and observational data. He is als

This report was prepared by Panchanok Muenkaew and Lapad Pongcharoenyong from the Health Intervention and Technology Assessment Program Foundation (HITAP), and reviewed by Saudamini Dabak. We would like to extend our sincere appreciation to Mark Landry from the World Health Organization (WHO), Thail